LAKE FOREST, CA -- (Marketwire) -- 02/12/10 -- CryoPort, Inc. (OTCBB: CYRXD) (NASDAQ: CYPT) today announced that it has decided to postpone its...
Calypte Biomedical Approved for Listing on AMEX: HIV Trading Expected to Begin Wednesday August 18th PLEASANTON, Calif., Aug. 16...
Calypte Biomedical Announces Second Quarter and Six-Month Financial Results PLEASANTON, Calif., Aug. 12 /PRNewswire-FirstCall/ -- Calypte...
Calypte Biomedical to Host 2nd Quarter Conference Call PLEASANTON, Calif., Aug. 10 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation...
Calypte Biomedical Announces Signing of Sublicense Agreement with Abbott Laboratories PLEASANTON, Calif., Aug. 9 /PRNewswire-FirstCall/...
Calypte Biomedical To Host Conference Call CEO to Discuss The International AIDS Conference and Recent Clinical Data Disclosed at Event...
Calypte Biomedical Issues Update on Informal SEC Inquiry PLEASANTON, Calif., July 19 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation...
Calypte Biomedical Presents Results of Its Rapid HIV-1/2 Field Trial Tests at the XV International AIDS Conference in Bangkok Overall Accuracy:...
Calypte Biomedical Raises an Additional $1.5 Million in Private Placement PLEASANTON, Calif., July 13 /PRNewswire-FirstCall/ -- Calypte...
Calypte Biomedical Announces Board Member Resignation PLEASANTON, Calif., July 1 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation...
Calypte's Rockville, Maryland Facility Receives Quality System Certification to ISO 13485:1996 Corporate Headquarters Moved to Pleasanton...
Calypte Files Registration Statement Registering Primarily Previously Issued Shares ALAMEDA, Calif., June 16 /PRNewswire-FirstCall/ -- Calypte...
Calypte Biomedical Raises $9.3 Million in Private Placement ALAMEDA, Calif., June 1 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation...
Calypte Developing HIV-1/2 Oral Fluid Rapid Tests Launch Expected During Second Half Of 2004 ALAMEDA, Calif., May 25 /PRNewswire-FirstCall/...
Calypte Announces First Quarter Financial Results ALAMEDA, Calif., May 13 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (BULLETIN...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.